246 related articles for article (PubMed ID: 11899748)
1. Current treatment options in systemic Sclerosis (Scleroderma).
Stummvoll GH
Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748
[TBL] [Abstract][Full Text] [Related]
2. Treatment of systemic sclerosis.
Pope JE
Rheum Dis Clin North Am; 1996 Nov; 22(4):893-907. PubMed ID: 8923602
[TBL] [Abstract][Full Text] [Related]
3. Treatment Algorithms for Systemic Sclerosis According to Experts.
Fernández-Codina A; Walker KM; Pope JE;
Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
[TBL] [Abstract][Full Text] [Related]
5. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
[TBL] [Abstract][Full Text] [Related]
6. [Management of patients with systemic sclerosis].
Wiesik-Szewczyk E; Olesińska M
Pol Merkur Lekarski; 2010 May; 28(167):421-3. PubMed ID: 20568411
[TBL] [Abstract][Full Text] [Related]
7. Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O; Fransen J; Avouac J; Becker M; Kulak A; Allanore Y; Distler O; Clements P; Cutolo M; Czirjak L; Damjanov N; Del Galdo F; Denton CP; Distler JHW; Foeldvari I; Figelstone K; Frerix M; Furst DE; Guiducci S; Hunzelmann N; Khanna D; Matucci-Cerinic M; Herrick AL; van den Hoogen F; van Laar JM; Riemekasten G; Silver R; Smith V; Sulli A; Tarner I; Tyndall A; Welling J; Wigley F; Valentini G; Walker UA; Zulian F; Müller-Ladner U;
Ann Rheum Dis; 2017 Aug; 76(8):1327-1339. PubMed ID: 27941129
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of systemic sclerosis].
van den Hoogen FH
Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640
[TBL] [Abstract][Full Text] [Related]
9. Treatment of systemic sclerosis.
Steen VD
Am J Clin Dermatol; 2001; 2(5):315-25. PubMed ID: 11721650
[TBL] [Abstract][Full Text] [Related]
10. Drug treatment of scleroderma.
Leighton C
Drugs; 2001; 61(3):419-27. PubMed ID: 11293650
[TBL] [Abstract][Full Text] [Related]
11. Systemic sclerosis: an update.
Varga J
Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis - a systematic overview: part 2 - immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension.
Opitz C; Klein-Weigel PF; Riemekasten G
Vasa; 2011 Jan; 40(1):20-30. PubMed ID: 21283970
[TBL] [Abstract][Full Text] [Related]
13. Treatment of complications associated with systemic sclerosis.
Moore SC; Desantis ER
Am J Health Syst Pharm; 2008 Feb; 65(4):315-21. PubMed ID: 18238768
[TBL] [Abstract][Full Text] [Related]
14. Current therapy of systemic sclerosis (scleroderma).
Müller-Ladner U; Benning K; Lang B
Clin Investig; 1993 Apr; 71(4):257-63. PubMed ID: 8471811
[TBL] [Abstract][Full Text] [Related]
15. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis.
Lin AT; Clements PJ; Furst DE
Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302
[TBL] [Abstract][Full Text] [Related]
16. Scleroderma and related disorders: therapeutic aspects.
Denton CP; Black CM
Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):17-35. PubMed ID: 10882212
[TBL] [Abstract][Full Text] [Related]
17. Current options for the treatment of systemic scleroderma.
McGee BA; Barnett MD; Small RE
Clin Pharm; 1991 Jan; 10(1):14-25. PubMed ID: 1999084
[TBL] [Abstract][Full Text] [Related]
18. Clinical approach to scleroderma.
White B
Semin Cutan Med Surg; 1998 Sep; 17(3):213-8. PubMed ID: 9759679
[TBL] [Abstract][Full Text] [Related]
19. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis.
Nagaraja V; Matucci-Cerinic M; Furst DE; Kuwana M; Allanore Y; Denton CP; Raghu G; Mclaughlin V; Rao PS; Seibold JR; Pauling JD; Whitfield ML; Khanna D
Arthritis Rheumatol; 2020 Jul; 72(7):1049-1058. PubMed ID: 32134199
[TBL] [Abstract][Full Text] [Related]
20. Early systemic sclerosis-opportunities for treatment.
Sakkas LI; Simopoulou T; Katsiari C; Bogdanos D; Chikanza IC
Clin Rheumatol; 2015 Aug; 34(8):1327-31. PubMed ID: 25711876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
